SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
vaccinia virus
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
12
1
RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA
2
Genome sequence of Vaccinia virus strain Lister- Butantan, a Lister vaccine variant used during a smallpox eradication campaign in Brazil
3
Administration with Vaccinia Virus Encoding Canine Parvovirus 2 Elicits Systemic Immune Responses in Mice and Dogs.
4
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.
5
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses
6
Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
7
Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies
8
Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model
9
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants
10
Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model
11
modified vaccinia virus ankara (mva) as production platform for vaccines against influenza and other viral respiratory diseases
12
serro 2 virus highlights the fundamental genomic and biological features of a natural vaccinia virus infecting humans